Dystrophin gene promoter and regulatory regions (DMD promoter) (DMD promoter)

The Dystrophin (DMD) gene promoter and regulatory regions are critical genomic sequences that control the expression of dystrophin, a vital protein for maintaining the structural integrity of muscle cell membranes (NCBI Gene ID: 1756). Located on the X chromosome, the DMD gene is the largest in the human genome and features multiple tissue-specific promoters, including those for muscle (M), brain (B), and Purkinje (P) cells (PubMed: 1848230). Mutations in these regulatory regions or the coding sequence lead to Duchenne and Becker muscular dystrophies, characterized by progressive muscle degeneration and cardiomyopathy (NIH: Genetic and Rare Diseases Information Center). As a therapeutic target, these DNA regions are approached using advanced genetic tools like CRISPR/Cas9 and dCas9-based transcriptional activators to either repair mutations or upregulate the expression of functional dystrophin isoforms (Nature Communications: 14454). Targeting the promoter allows for the potential restoration of endogenous protein production, offering a more comprehensive treatment than traditional exon-skipping or micro-dystrophin gene therapies (Molecular Therapy: S1525-0016(17)30544-X). This target is particularly relevant for patients with large deletions where the promoter remains intact but the downstream coding sequence is disrupted.

Other names

DMD gene regulatory elementsDystrophin promoterDMD enhancer regionsDMD locus control regionDouble-stranded DNA in the DMD gene promoter

Modulation of gene expression through site-specific DNA binding to induce transcriptional activation, gene editing, or epigenetic modification of the dystrophin locus.